HK Stock MarketDetailed Quotes

01931 IVD MEDICAL

Watchlist
  • 1.640
  • +0.010+0.61%
Market Closed Nov 15 16:08 CST
2.67BMarket Cap9.32P/E (TTM)

IVD MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-1.73%1.35B
12.35%3.09B
17.06%1.38B
0.66%2.75B
-0.86%1.18B
12.46%2.73B
20.95%1.19B
4.09%2.43B
7.50%981.24M
463.96%2.33B
Operating income
-1.73%1.35B
12.35%3.09B
17.06%1.38B
0.66%2.75B
-0.86%1.18B
12.46%2.73B
20.95%1.19B
4.09%2.43B
7.50%981.24M
463.96%2.33B
Cost of sales
4.37%-1.03B
-12.89%-2.42B
-18.20%-1.08B
1.10%-2.14B
3.88%-910.13M
-10.88%-2.16B
-20.31%-946.9M
-3.29%-1.95B
-12.82%-787.06M
-536.39%-1.89B
Operating expenses
4.37%-1.03B
-12.89%-2.42B
-18.20%-1.08B
1.10%-2.14B
3.88%-910.13M
-10.88%-2.16B
-20.31%-946.9M
-3.29%-1.95B
-12.82%-787.06M
-536.39%-1.89B
Gross profit
7.68%324.69M
10.45%671.7M
13.18%301.54M
7.39%608.14M
11.06%266.42M
18.92%566.27M
23.54%239.89M
7.52%476.17M
-9.75%194.18M
279.60%442.88M
Selling expenses
0.79%-60.09M
-16.27%-136.31M
-31.67%-60.57M
4.35%-117.24M
0.60%-46M
-15.98%-122.57M
-15.94%-46.28M
-9.38%-105.68M
-17.37%-39.92M
-730.71%-96.62M
Administrative expenses
-5.89%-76.17M
-4.62%-159.98M
7.06%-71.93M
16.83%-152.92M
2.27%-77.4M
-27.59%-183.85M
7.70%-79.19M
-15.57%-144.09M
-106.66%-85.8M
-127.94%-124.68M
Revaluation surplus
99.64%-6K
-80.10%-20.63M
76.39%-1.65M
-182.30%-11.46M
-4,206.47%-6.98M
206.43%13.92M
-55.96%170K
--4.54M
--386K
----
-Changes in the fair value of financial assets
99.64%-6K
-80.10%-20.63M
76.39%-1.65M
-182.30%-11.46M
-4,206.47%-6.98M
206.43%13.92M
-55.96%170K
--4.54M
--386K
----
Impairment and provision
-715.22%-566K
----
--92K
----
----
----
----
----
----
----
-Other impairment is provision
-715.22%-566K
----
--92K
----
----
----
----
----
----
----
Operating interest expense
----
31.20%-21.04M
----
-49.74%-30.58M
-33.46%-11.91M
13.99%-20.42M
28.11%-8.93M
-205.05%-23.75M
-278.97%-12.42M
---7.78M
Special items of operating profit
-56.86%8.18M
322.58%27.29M
193.00%18.96M
-273.71%-12.26M
-242.79%-20.38M
-69.98%7.06M
108.35%14.28M
-70.98%23.52M
61.64%6.85M
1,271.98%81.05M
Operating profit
5.15%196.04M
27.26%361.03M
79.70%186.44M
8.94%283.69M
-13.50%103.75M
12.87%260.41M
89.53%119.94M
-21.75%230.71M
-54.99%63.28M
578.94%294.85M
Financing cost
-8.29%-11.63M
----
---10.74M
----
----
----
----
----
----
----
Share of profits of associates
70.09%-3.63M
-3,501.41%-16.84M
-2,262.03%-12.13M
-27.53%495K
96.84%561K
6.39%683K
51.60%285K
-73.01%642K
-96.33%188K
-96.89%2.38M
Share of profit from joint venture company
56.11%-291K
-353.13%-5.82M
-206.94%-663K
-69.94%2.3M
-21,500.00%-216K
11,872.31%7.65M
---1K
---65K
----
----
Special items of earning before tax
----
135.56%958K
----
-236.75%-2.69M
52.41%-603K
-219.58%-800K
59.36%-1.27M
329.90%669K
-101.61%-3.12M
87.54%-291K
Earning before tax
10.79%180.49M
19.57%339.33M
57.41%162.91M
5.92%283.79M
-13.00%103.5M
15.51%267.94M
97.10%118.96M
-21.88%231.96M
-82.22%60.35M
152.45%296.94M
Tax
10.15%-52.93M
-15.80%-102.2M
-74.31%-58.91M
16.89%-88.26M
18.76%-33.79M
-37.31%-106.19M
-71.46%-41.6M
-83.61%-77.34M
44.68%-24.26M
-132.53%-42.12M
After-tax profit from continuing operations
22.66%127.57M
21.27%237.13M
49.21%104M
20.88%195.53M
-9.90%69.7M
4.61%161.75M
114.34%77.36M
-39.32%154.62M
-87.79%36.09M
156.08%254.82M
Earning after tax
22.66%127.57M
21.27%237.13M
49.21%104M
20.88%195.53M
-9.90%69.7M
4.61%161.75M
114.34%77.36M
-39.32%154.62M
-87.79%36.09M
156.08%254.82M
Minority profit
129.41%2.28M
92.83%-1.04M
108.67%993K
-13.12%-14.47M
-650.20%-11.45M
-211.98%-12.79M
30.29%-1.53M
79.68%-4.1M
22.84%-2.19M
-413.28%-20.18M
Profit attributable to shareholders
21.63%125.29M
13.41%238.16M
26.94%103.01M
20.31%210M
2.87%81.15M
9.97%174.54M
106.07%78.89M
-42.28%158.72M
-87.18%38.28M
165.86%275M
Basic earnings per share
21.65%0.0927
12.88%0.1762
25.54%0.0762
18.35%0.1561
1.85%0.0607
10.56%0.1319
107.67%0.0596
-50.80%0.1193
-90.87%0.0287
44.78%0.2425
Diluted earnings per share
21.65%0.0927
13.68%0.1762
27.42%0.0762
19.78%0.155
1.70%0.0598
9.11%0.1294
105.59%0.0588
-44.79%0.1186
-90.91%0.0286
28.24%0.2148
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -1.73%1.35B12.35%3.09B17.06%1.38B0.66%2.75B-0.86%1.18B12.46%2.73B20.95%1.19B4.09%2.43B7.50%981.24M463.96%2.33B
Operating income -1.73%1.35B12.35%3.09B17.06%1.38B0.66%2.75B-0.86%1.18B12.46%2.73B20.95%1.19B4.09%2.43B7.50%981.24M463.96%2.33B
Cost of sales 4.37%-1.03B-12.89%-2.42B-18.20%-1.08B1.10%-2.14B3.88%-910.13M-10.88%-2.16B-20.31%-946.9M-3.29%-1.95B-12.82%-787.06M-536.39%-1.89B
Operating expenses 4.37%-1.03B-12.89%-2.42B-18.20%-1.08B1.10%-2.14B3.88%-910.13M-10.88%-2.16B-20.31%-946.9M-3.29%-1.95B-12.82%-787.06M-536.39%-1.89B
Gross profit 7.68%324.69M10.45%671.7M13.18%301.54M7.39%608.14M11.06%266.42M18.92%566.27M23.54%239.89M7.52%476.17M-9.75%194.18M279.60%442.88M
Selling expenses 0.79%-60.09M-16.27%-136.31M-31.67%-60.57M4.35%-117.24M0.60%-46M-15.98%-122.57M-15.94%-46.28M-9.38%-105.68M-17.37%-39.92M-730.71%-96.62M
Administrative expenses -5.89%-76.17M-4.62%-159.98M7.06%-71.93M16.83%-152.92M2.27%-77.4M-27.59%-183.85M7.70%-79.19M-15.57%-144.09M-106.66%-85.8M-127.94%-124.68M
Revaluation surplus 99.64%-6K-80.10%-20.63M76.39%-1.65M-182.30%-11.46M-4,206.47%-6.98M206.43%13.92M-55.96%170K--4.54M--386K----
-Changes in the fair value of financial assets 99.64%-6K-80.10%-20.63M76.39%-1.65M-182.30%-11.46M-4,206.47%-6.98M206.43%13.92M-55.96%170K--4.54M--386K----
Impairment and provision -715.22%-566K------92K----------------------------
-Other impairment is provision -715.22%-566K------92K----------------------------
Operating interest expense ----31.20%-21.04M-----49.74%-30.58M-33.46%-11.91M13.99%-20.42M28.11%-8.93M-205.05%-23.75M-278.97%-12.42M---7.78M
Special items of operating profit -56.86%8.18M322.58%27.29M193.00%18.96M-273.71%-12.26M-242.79%-20.38M-69.98%7.06M108.35%14.28M-70.98%23.52M61.64%6.85M1,271.98%81.05M
Operating profit 5.15%196.04M27.26%361.03M79.70%186.44M8.94%283.69M-13.50%103.75M12.87%260.41M89.53%119.94M-21.75%230.71M-54.99%63.28M578.94%294.85M
Financing cost -8.29%-11.63M-------10.74M----------------------------
Share of profits of associates 70.09%-3.63M-3,501.41%-16.84M-2,262.03%-12.13M-27.53%495K96.84%561K6.39%683K51.60%285K-73.01%642K-96.33%188K-96.89%2.38M
Share of profit from joint venture company 56.11%-291K-353.13%-5.82M-206.94%-663K-69.94%2.3M-21,500.00%-216K11,872.31%7.65M---1K---65K--------
Special items of earning before tax ----135.56%958K-----236.75%-2.69M52.41%-603K-219.58%-800K59.36%-1.27M329.90%669K-101.61%-3.12M87.54%-291K
Earning before tax 10.79%180.49M19.57%339.33M57.41%162.91M5.92%283.79M-13.00%103.5M15.51%267.94M97.10%118.96M-21.88%231.96M-82.22%60.35M152.45%296.94M
Tax 10.15%-52.93M-15.80%-102.2M-74.31%-58.91M16.89%-88.26M18.76%-33.79M-37.31%-106.19M-71.46%-41.6M-83.61%-77.34M44.68%-24.26M-132.53%-42.12M
After-tax profit from continuing operations 22.66%127.57M21.27%237.13M49.21%104M20.88%195.53M-9.90%69.7M4.61%161.75M114.34%77.36M-39.32%154.62M-87.79%36.09M156.08%254.82M
Earning after tax 22.66%127.57M21.27%237.13M49.21%104M20.88%195.53M-9.90%69.7M4.61%161.75M114.34%77.36M-39.32%154.62M-87.79%36.09M156.08%254.82M
Minority profit 129.41%2.28M92.83%-1.04M108.67%993K-13.12%-14.47M-650.20%-11.45M-211.98%-12.79M30.29%-1.53M79.68%-4.1M22.84%-2.19M-413.28%-20.18M
Profit attributable to shareholders 21.63%125.29M13.41%238.16M26.94%103.01M20.31%210M2.87%81.15M9.97%174.54M106.07%78.89M-42.28%158.72M-87.18%38.28M165.86%275M
Basic earnings per share 21.65%0.092712.88%0.176225.54%0.076218.35%0.15611.85%0.060710.56%0.1319107.67%0.0596-50.80%0.1193-90.87%0.028744.78%0.2425
Diluted earnings per share 21.65%0.092713.68%0.176227.42%0.076219.78%0.1551.70%0.05989.11%0.1294105.59%0.0588-44.79%0.1186-90.91%0.028628.24%0.2148
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion------Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data